Molecular imaging agents continue to play an increasingly important role in modern healthcare - Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) are remarkably sensitive noninvasive imaging techniques which provide valuable information at the cellular level. These imaging agents (also known as radiopharmaceuticals) contain a radioisotope incorporated into drug molecules and are widely used to diagnose neurology, oncology and cardiovascular diseases. A/Prof Bhalla’s research focuses on the development of new labelling strategies (and chemistry) for a wide range of radioisotopes (including F-18, C-11, Ga-68, Tc-99m, I-123, I-124 and Cu-64) which will support the synthesis of novel PET and SPECT diagnostic agents. A/Prof Bhalla also has a strong interest in the development of new simpler automated synthesis platforms which will support the translation of these imaging agents into the clinic.
Keywords: radiochemistry, PET, SPECT, automation
See the Bhalla Laboratory page for current group members.